Statement of Ethics
Cancer
CANCER
The study was approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board IRB. The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The subjects provided their WRITTEN informed consent to participate in the IRB approved protocol 17-406. B.M.W. has received research funding from Celgene and Eli Lilly, and consulting fees from Celgene, Grail, and Mirati, unrelated to the present work.